Breathe Well Live Well
|
Vectura Inks Asthma/COPD License Agreement with Janssen
Genetic Engineering & Biotechnology News Vectura, a respiratory product development company, has entered a license agreement with Janssen Biotech to exclusively develop anti-inflammatory therapies for the treatment of asthma/COPD. The collaboration will initially focus on the development of a … |
View full post on asthma – Google News
|
AstraZeneca And Rigel Sign Worldwide License Agreement For A …
MarketWatch (press release) "R256 emerged from Rigel's comprehensive study of chronic and severe asthma and lung inflammation. With AstraZeneca as our development partner, severely … |
View full post on asthma – Google News
|
Coolabi and Asthma extend Bagpuss license
Kidscreen UK-based family entertainment producer and rights management company Coolabi has locked down a two-year extension on its promotional relationship for Bagpuss with charity Asthma UK. The deal will see Asthma UK expand the number of stores that sell … |
View full post on asthma – Google News
|
Kos Pharmaceuticals and SkyePharma terminate license agreement for flutiform
Trading Markets (press release) Flutiform is used for adult and adolescent asthma. Under the terms of the agreement, Kos has the right to perform further clinical development for … Abbott, Skyepharma Part Ways On Asthma Drug Flutiform |
View full post on asthma – Google News